Cargando…
Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
Obesity is a well-established cardiovascular (CV) risk factor with greater mortality and morbidity rates than the general population. Phentermine is a weight loss medication that is approved for short-term obesity treatment in conjunction with lifestyle modifications to decrease CV risk. A 51-year-o...
Autores principales: | Sendil, Selin, Gjergjindreaj, Medeona, Lozier, Matthew, Fernandez, Rafle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805544/ https://www.ncbi.nlm.nih.gov/pubmed/36601192 http://dx.doi.org/10.7759/cureus.32138 |
Ejemplares similares
-
Coronary Steal Syndrome Secondary to Large Coronary to Pulmonary Artery Fistulas
por: Torres, Christian, et al.
Publicado: (2022) -
Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
por: Elkholy, Karim O, et al.
Publicado: (2021) -
Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report
por: Farid, Saira, et al.
Publicado: (2020) -
A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022) -
Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)